IDH1 and spinal cord astrocytoma: Although IDH1 mutations frequently occur in brain astrocytomas and rarely in pediatric age, the incidence of IDH1 mutations in spinal cord astrocytomas has been found to be rather low, excluding enasidenib and ivosidenib from potential therapies [107].